THALAGEN Trademark

Trademark Overview


On Friday, June 11, 2010, a trademark application was filed for THALAGEN with the United States Patent and Trademark Office. The USPTO has given the THALAGEN trademark a serial number of 85060357. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 13, 2018. This trademark is owned by Errant Gene Therapeutics, LLC. The THALAGEN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products and preparations in the form of a suspension intravenously administered to the patients for the treatment of thalassemia and sickle cell anemia, for use in connection with bone marrow transplants
thalagen

General Information


Serial Number85060357
Word MarkTHALAGEN
Filing DateFriday, June 11, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 13, 2018
Registration Number4023649
Registration DateTuesday, September 6, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 23, 2010

Trademark Statements


Goods and ServicesPharmaceutical products and preparations in the form of a suspension intravenously administered to the patients for the treatment of thalassemia and sickle cell anemia, for use in connection with bone marrow transplants

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 13, 2018
Primary Code005
First Use Anywhere DateMonday, August 2, 2010
First Use In Commerce DateMonday, August 2, 2010

Trademark Owner History


Party NameErrant Gene Therapeutics, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressChicago, IL 60661

Party NameErrant Gene Therapeutics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressChicago, IL 60661

Party NameErrant Gene Therapeutics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressChicago, IL 60606

Trademark Events


Event DateEvent Description
Friday, April 13, 2018CANCELLED SEC. 8 (6-YR)
Tuesday, September 6, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, August 2, 2011NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, August 1, 2011LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, August 1, 2011ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, July 26, 2011STATEMENT OF USE PROCESSING COMPLETE
Friday, July 15, 2011USE AMENDMENT FILED
Tuesday, July 26, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, July 15, 2011TEAS STATEMENT OF USE RECEIVED
Tuesday, January 18, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 23, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 23, 2010PUBLISHED FOR OPPOSITION
Wednesday, October 20, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 20, 2010ASSIGNED TO LIE
Tuesday, October 5, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 21, 2010ASSIGNED TO EXAMINER
Wednesday, June 16, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, June 15, 2010NEW APPLICATION ENTERED IN TRAM